SCHEMBL6556722

SCHEMBL6556722

CCOc1cc(Cc2cnc(N)nc2N)cc(OCCc2ccccn2)c1-c1cccc(N)c1

nearest known ligand 0.53

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
DHFR P00374 4/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6555538 0.88 DHFR (0.60) DHFR
SCHEMBL6555137 0.88 DHFR (0.48) DHFR
SCHEMBL6555073 0.85 DHFR (0.47) DHFR
SCHEMBL6557494 0.84 DHFR (0.60) DHFR
SCHEMBL6555356 0.83 DHFR (0.56) DHFR
SCHEMBL6555486 0.83 DHFR (0.55) DHFR
SCHEMBL7572441 0.82 DHFR (0.52) DHFR
SCHEMBL6555402 0.81 DHFR (0.53) DHFR
SCHEMBL6555409 0.81 DHFR (0.64) DHFR
SCHEMBL6873198 0.80 DHFR (0.52) DHFR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1230224-B1 SUBSTITUTED 5-BENZYL-2,4-DIAMINOPYRIMIDINES BASILEA PHARMACEUTICA AG (CH) 2004-12-29 EP disclosed
US-6821980-B1 Substituted 5-benzyl-2,4-diaminopyrimidines BASILEA PHARMACEUTICA AG (CH) 2004-11-23 US disclosed
EP-1230224-A1 SUBSTITUTED 5-BENZYL-2,4-DIAMINOPYRIMIDINES F. HOFFMANN-LA ROCHE AG (CH) 2002-08-14 EP disclosed
WO-2001032633-A1 SUBSTITUTED 5-BENZYL-2,4-DIAMINOPYRIMIDINES BASILEA PHARMACEUTICA AG (CH) 2001-05-10 WO disclosed